The new rule includes language from Congressman Gonzalez’s PHAIR Pricing Act
Texas Border Business
WASHINGTON – Congressman Vicente Gonzalez (TX-15) today announced that the Centers for Medicare and Medicaid Services has issued a proposed rule that lowers prescription drug costs and increases transparency surrounding Medicare Parts C and D.
In May 2018, Congressmen Gonzalez and Doug Collins (GA-09) introduced the bipartisan H.R. 5958, the PHAIR Pricing Act of 2018, to lower drug costs to Medicare recipients at the point of sale. The new rule includes language from this bill.
“Medicare recipients deserve transparency,” Congressman Gonzalez said. “Prescription drug prices should not be decided behind a curtain and the final cost should not be equal to almost 50 percent above the negotiated price. The road to fixing America’s prescription drug market may be long, but I commend the Centers for Medicare and Medicaid Services for taking this important step.”
Congressman Gonzalez has pledged to make it his mission in Congress to make affordable, accessible healthcare and prescription drugs readily available to Central and South Texans.
